News for Otsuka Holdings Co., Ltd. (4578.T)

Published at

Jun 1, 2025 4:00 PM

by gurufocus.com

neutral

neutral

Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology

PR NewswirePRINCETON, N.J. and CAMBRIDGE, Mass., June 1, 2025 PRINCETON, N.J. and CAMBRIDGE, Mass., June 1, 2025 /PRNewswire/ -- Taiho Oncology, Inc., and

OTSKY OTSKF 4578.T

Read more →
Published at

May 23, 2025 1:00 AM

by gurufocus.com

positive

positive

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co.,

OTSKY OTSKF 4578.T

Read more →
Published at

May 23, 2025 1:00 AM

by gurufocus.com

positive

positive

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. ( CGEM), Taiho Pharmaceutical Co., Ltd., a

OTSKY OTSKF 4578.T

Read more →
Published at

May 22, 2025 11:21 PM

by manilatimes.net

positive

positive

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

**media[634777,634778,634779]**

OTSKY OTSKF 4578.T

Read more →
Published at

May 17, 2025 9:00 AM

by gurufocus.com

neutral

neutral

Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension

PR NewswirePALO ALTO, Calif., FRANKFURT, Germany, May 17, 2025 World Hypertension Day's focus on High Blood Pressure Awareness, Management and Control high

OTSKY OTSKF 4578.T

Read more →
Published at

May 16, 2025 4:18 PM

by manilatimes.net

neutral

neutral

Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension

**media[628399,628400,628401]**

OTSKY OTSKF 4578.T

Read more →
Published at

May 1, 2025 4:00 PM

by gurufocus.com

positive

positive

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

PR NewswireSAN CLEMENTE, Calif. and TOKUSHIMA, Japan, May 1, 2025 The partnership creates one of the largest global IV solutions manufacturing networks wit

OTSKY OTSKF ICUI 4578.T

Read more →
Published at

Apr 15, 2025 1:56 AM

by gurufocus.com

positive

positive

Otsuka Holdings Co Ltd (TSE:4578) in Artisan International Fund Q3 2024

Strong presence in pharmaceuticals, nutraceuticals, and medical devices.Focus on innovation and global market expansion.Risks include patent expirations and re

OTSKY OTSKF 4578.T

Read more →
Published at

Mar 26, 2025 2:50 PM

by manilatimes.net

positive

positive

Dietary Supplements Industry Poised for $258.75 Billion Growth by 2029

**media[577472]**

OTSKY OTSKF NATR GLB.L GLAPY GLAPF GL9.IR 4578.T

Read more →
Published at

Mar 17, 2025 9:57 AM

by manilatimes.net

positive

positive

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion

**media[568068]**

OTSKY OTSKF 4578.T

Read more →
Published at

Mar 17, 2025 9:37 AM

by manilatimes.net

positive

positive

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech

**media[568061]**

OTSKY OTSKF 4578.T

Read more →
Published at

Feb 17, 2025 12:00 PM

by gurufocus.com

neutral

neutral

Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O N4578.T - Otsuka Holdings Co LtdFull Year 2024 Otsuka Holdings Co Ltd Earnings PresentationFeb

OTSKY OTSKF 4578.T

Read more →
Published at

Nov 14, 2024 9:42 AM

by medium.com

mixed

mixed

Top Companies In The Autism Spectrum Disorder Treatment Market

The Autism Spectrum Disorder Treatment Market Size sector reached a market value of USD 6.94 billion in 2022. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of…

OTSKY OTSKF 4578.T PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ DJNJ3.BA DJNJ2.BA 0Q1G.L

Read more →
Published at

Nov 2, 2024 12:06 AM

by manilatimes.net

neutral

neutral

Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor's Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension

**media[454122,454123,454124]**

OTSKY OTSKF 4578.T

Read more →
Published at

Nov 1, 2024 8:48 AM

by seekingalpha.com

neutral

neutral

Otsuka Holdings Co., Ltd. reports Q3 results (OTCMKTS:OTSKF)

Otsuka Holdings Co., Ltd. reported a significant increase in revenue and profit for the nine-month period ended September 30.

OTSKY OTSKF 4578.T

Read more →
Published at

Oct 17, 2024 10:21 AM

by medium.com

mixed

mixed

U.S. Autism Spectrum Disorder Therapeutics Market: Evolving Treatments for Neurodevelopmental Disorders

According to a report by Fortune Business Insights, the U.S. Autism Spectrum Disorder Therapeutics Market size sector reached a market value of USD 1.04 Billion in 2022. Future projections show a…

OTSKY OTSKF APLLTD.NS APLLTD.BO 4578.T HLUYY HLUKF

Read more →
Published at

Sep 17, 2024 2:30 PM

by globenewswire.com

mixed

mixed

Mental Health Market to Surpass Market Valuation of USD 544.63 Billion by 2031 | SkyQuest Technology

Global Mental Health Market size was valued at USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period...

JAZZN.MX JAZZ HKMPY HKMPF HIK.L TKPHF TAKP34.SA TAKN.MX TAK SUNPHARMA-BL.NS HLUYY HLUKF GIS.DE GILDD.BA GILD.MX GILD AMGN.MX AMGN.BA AMGN AMG.DE ALKS ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 4502.T 4502.S 0A87.L PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE OTSKY OTSKF MRKD.BA MRK.SN MRK.PA MRK.MX MRK LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ DJNJ3.BA DJNJ2.BA 6MK.DE 4578.T 0Q1G.L

Read more →
Published at

Sep 13, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Bipolar Disorder Market Size to Reach USD 7 Billion by 2033, Says The Brainy Insights

The bipolar disorder market is poised for significant expansion from 2024 to 2033. While exact figures are proprietary, industry experts project a compound...

OTSKY OTSKF NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JNJ DJNJ3.BA DJNJ2.BA ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 4578.T 0K9E.L PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Sep 13, 2024 2:00 PM

by globenewswire.com

mixed

mixed

Dietary Supplements Market to Reach USD 63.93 Billion by 2031, Growing at 7.4% CAGR | SkyQuest Technology

Westford, USA, Sept. 13, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Dietary Supplements Market will attain a value of USD 283 billion by 2031,...

GNC GLB.L GLAPY GLAPF GL9.IR ARHVF ADM.MX ADM.DE ADM ABTCL.SN ABT.SN ABT A1DM34.SA 0JQQ.L HLF PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE OTSKY OTSKF OSUKF NSRGY NSRGF NESNN.MX NESNE.SW NESN.SW NESM.DE GSK.L GSK GS7.DE GLAXF 4578.T

Read more →
Published at

Aug 21, 2024 10:45 AM

by medium.com

mixed

mixed

What is the Current Market Trend for U.S. Autism Spectrum Disorder Therapeutics?

A Analysis from Fortune Business Insight’s, the U.S. autism spectrum disorder therapeutics Market share sector attained a worth of USD 1.04 Billion in 2022. Forecasts indicate a promising path ahead…

OTSKY OTSKF APLLTD.NS APLLTD.BO 4578.T HLUYY HLUKF

Read more →